Thought Leadership – PROMETRIKA CRO

April 27 2017 Tahmeena Chowdhury, PhD

Targeting Toxic Proteins: Novel Drug Approaches to Defeat Dementias

Genetic Engineering and Biotechnology News (December 16, 2016) discusses the challenges posed by the complex pathogenesis of Alzheimer’s disease (AD) and other related diseases to treatment approaches.

April 20 2017 Tahmeena Chowdhury, PhD

The End of Alzheimer’s disease

This session presented an excellent opportunity to hear from panelists, Drs. Sarah Hopp (Massachusetts General Hospital), Matt Kaeberlein (University of Washington, Seattle), and Anant Paravastu (Georgia Tech), on new developments and potential therapies targeting this debilitating neurological disorder.

April 18 2017 Stephen Cropper, MS

Observations from the MassBio 2017 Annual Meeting

The Massachusetts Biotechnology Council (MassBio) is a not-for-profit organization focused on supporting and advancing the thriving life sciences “ecosystem” in Massachusetts.

April 10 2017 LuAnn Sabounjian

Rare Disease Clinical Development: The Crucial Need for Patient and Parent Involvement

February 28th, 2017 was the tenth observance of Rare Disease Day worldwide. Rare Disease Day awareness events took place in over 80 countries through the collaboration of countless foundations and patient advocacy organizations.

April 7 2017 LuAnn Sabounjian

A Case Study: Complex Oncology Study and the Boutique CRO that Provides the Perfect Model

In assembling a team for a new trial studying a rare form of cancer, acute myeloid leukemia (AML), a prestigious cancer research center was looking for a CRO partner with unique qualities.